Global Liver Institute
News
GLOBAL LIVER INSTITUTE
Global Liver Institute Recognized with Two Advocacy Awards for Enduring Contributions and Sustained Service
Donna R. Cryer, JD, President and CEO, Honored with Awards from the American Association for the Study of Liver Diseases (AASLD) and Global Genes for leadership in connecting, empowering, inspiring and advocating for people living with liver disease…
Liver Advocacy Community Advancements
The liver advocacy community — with the GLI Liver Action Network leading the way — has elevated patient voices through a variety of initiatives throughout September and October. Here are some advocacy highlights that have occurred over the past month…
Empowered Nutrition is the Key to Better Liver Health
People living with serious and chronic illnesses benefit from eating foods that are healthful in relation to their diagnosis. While a liver patient’s journey may feel hectic or their daily schedules impacted by requirements for treatment regimens, there is one aspect that they can help manage — their food. Nutrition is one of the most important aspects a patient can learn to manage regarding their health…
CDC Dear Colleague Highlighting Liver Cancer Awareness Month
October is Liver Cancer Awareness Month. This represents an opportunity to draw attention to the global burden of liver cancer and to highlight the various public health organizations, scientific societies, and individuals making liver cancer awareness and education a priority…
Global Liver Institute Holds Externally-Led Patient Focused Drug Development Meeting Nonalcoholic Steatohepatitis (NASH)
Up to 444 million people worldwide, including 40 million in the United States, are estimated to be living with the progressive, chronic liver condition nonalcoholic steatohepatitis (NASH), the advanced form of fatty liver disease (NAFLD). Current estimates show that more than 1 in 4 adults have NAFLD, and up to 6% have NASH…
Global Liver Institute Applauds Congresswoman Velázquez and Senator Duckworth for Bold Action on Liver Cancer
(Washington, DC, Friday, October 22, 2021)—Global Liver Institute (GLI) CEO and President, Donna R. Cryer, JD, yesterday applauded the actions of U.S. Representative Nydia Velázquez (D-NY), and U.S. Senator Tammy Duckworth (D-IL) to improve the lives of all people impacted by liver disease…
The Power of Advocacy
Liver diseases affect a wide range of people spanning a plethora of ages, genders, socio-economic statuses, and ethnicities. To ensure this diverse population is represented, it is crucial for these patients and family members to have the opportunity to become advocates…
Patient-Driven Transformation is Key to NASH Clinical Trials
There is not a day that passes that I do not receive a call to help recruit for a clinical trial. The efforts to reach out to patients seem ad hoc, scattershot, and an afterthought to rescue research and recruitment plans that fail to resonate when faced with the realities of a competitive trials landscape in a disease state with low awareness…
Q&A on a Third Vaccine Dose for Immunocompromised Individuals
The Global Liver Institute (GLI) has been consistent, since March 2020, in advocating for the prioritization of liver patients, cancer patients, transplant recipients, and those with compromised immune systems in research, healthcare, and vaccine allocation strategies. We have taken data…
Global Liver Institute Applauds FDA and CDC Actions to Approve Third COVID-19 Vaccine Dose for Immunocompromised Individuals
(Washington, D.C., Friday, August 13, 2021)—Global Liver Institute (GLI) CEO and President Donna R. Cryer, JD, today applauded dual actions from U.S. government health agencies: U.S. Food and Drug Administration approval of an additional COVID-19 mRNA vaccine dose for organ…
Prioritizing Liver Health in ARPA-H
Recently, Global Liver Institute (GLI) sent a letter to U.S. Representatives Diana DeGette and Fred Upton in response to their request for stakeholder input on the development of a new Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health…
GLI Response to Updated Organ Transplant Societies’ Statement on Vaccine Efficacy in Transplant Recipients
Global Liver Institute has consistently advocated for a more muscular and proactive set of solutions for transplant recipients, cancer patients, and individuals with compromised immune systems during the COVID-19 pandemic. Essential to this is strong leadership…